Showing 781 - 800 results of 7,701 for search '"Beijing"', query time: 0.05s Refine Results
  1. 781
  2. 782
  3. 783
  4. 784
  5. 785
  6. 786
  7. 787
  8. 788
  9. 789
  10. 790
  11. 791
  12. 792
  13. 793
  14. 794
  15. 795

    Inosine enhances the efficacy of immune‐checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study by Haiqing Zhao, Wei Zhang, Yuting Lu, Yin Dong, Zhihao He, Hongchao Zhen, Qin Li

    Published 2024-09-01
    “…Methods This single‐center, prospective, randomized, open‐label study was conducted, from January 2021 to December 2022, in Beijing Friendship Hospital, Capital Medical University, and participants were randomly assigned (1:1) to either the inosine (trial) or non‐inosine (control) group that received inosine (dosage: 0.2 g, three times/day) + PD‐1/PD‐L1 inhibitor or only PD‐1/PD‐L1 inhibitor ± targeted ± chemotherapy, respectively. …”
    Get full text
    Article
  16. 796
  17. 797
  18. 798
  19. 799
  20. 800